Why did China’s zero-COVID policy persist?: decision urgency, regime type and political opportunity structures/ Shu Keng, Lingna Zhong and Fang Xie
Publication details: 2024Subject(s): Online resources: In: Journal of Contemporary China, Vol 33, Number 146, March 2024, page: 206-222Summary: Despite soaring social costs, opposed professional opinions, and divergent foreign experiences, China still persisted with its Zero-COVID policy. Preexisting theories of policy change are unable to explain the continuation of China’s COVID policy. Corresponding to the three stages of policy making, implementation and adjustment, the authors propose a framework of three decision-making constraints: (1) decision urgency, (2) regime type, and (3) political opportunity structures, which are believed to jointly shape China’s policy against Omicron and obstruct Chinese decision-makers from adjusting it. This intensive case study enriches understanding of China’s COVID policy specifically and the policy process in China more generally.Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Journal Article | Mindef Library & Info Centre Journals | COVID-19 (Browse shelf(Opens below)) | Not for loan |
Browsing Mindef Library & Info Centre shelves, Shelving location: Journals Close shelf browser (Hides shelf browser)
Despite soaring social costs, opposed professional opinions, and divergent foreign experiences, China still persisted with its Zero-COVID policy. Preexisting theories of policy change are unable to explain the continuation of China’s COVID policy. Corresponding to the three stages of policy making, implementation and adjustment, the authors propose a framework of three decision-making constraints: (1) decision urgency, (2) regime type, and (3) political opportunity structures, which are believed to jointly shape China’s policy against Omicron and obstruct Chinese decision-makers from adjusting it. This intensive case study enriches understanding of China’s COVID policy specifically and the policy process in China more generally.
CHINA, COVID, POLICY, NEWARTICLS
There are no comments on this title.